Depositary Receipt on ALAB Issued by INVX's next confirmed earnings release is scheduled for November 3, 2026.
| Earnings Date | 11/3/2026 |
As of June 30, 2026, Depositary Receipt on ALAB Issued by INVX has 868.59B shares outstanding.
| Shares Outstanding | 868.59B |
As of June 30, 2026, Depositary Receipt on ALAB Issued by INVX maintains a current ratio of 10.05, meaning it holds 10.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 10.05 |
| Quick Ratio | 9.16 |
Over the twelve months ended June 30, 2026, Depositary Receipt on ALAB Issued by INVX posted a return on equity (ROE) of 25.83, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 23.07, measuring how efficiently the asset base is converted into earnings. The company generates approximately 58.99M in revenue per employee across its workforce of 677.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.47 indicates how many times Depositary Receipt on ALAB Issued by INVX sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 25.83 |
| Return on Assets (ROA) | 23.07 |
| Revenue Per Employee | 58.99M |
| Employee Count | 677.00 |
| Inventory Turnover | 3.47 |
Over the twelve months ended June 30, 2026, Depositary Receipt on ALAB Issued by INVX recorded an income tax benefit of -1.58B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 10.70B, leaving 12.28B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | -1.58B |
Over the twelve months ended June 30, 2026, Depositary Receipt on ALAB Issued by INVX generated 39.94B in revenue and converted that into 12.28B in net income, yielding earnings per share of 0.01. EBITDA reached 9.48B, while operating income came in at 9.09B.
| Revenue | 39.94B |
| Gross Profit | 30.00B |
| Operating Income | 9.09B |
| Pretax Income | 10.70B |
| Net Income | 12.28B |
| EBITDA | 9.48B |
| EBIT | 9.09B |
| Earnings Per Share (EPS) | 0.01 |
These figures are as of June 30, 2026. Total book value stands at 57.34B, with working capital of 49.43B providing operational flexibility.
| Cash & Cash Equivalents | 41.63B |
| Net Debt | -3.70B |
| Equity (Book Value) | 57.34B |
| Book Value Per Share | 0.07 |
| Working Capital | 49.43B |
Depositary Receipt on ALAB Issued by INVX produced 11.15B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.96B in capital expenditures, free cash flow totaled 9.19B - equivalent to 0.01 per share.
| Operating Cash Flow | 11.15B |
| Capital Expenditures | -1.96B |
| Free Cash Flow | 9.19B |
| FCF Per Share | 0.01 |
Over the twelve months ended June 30, 2026, Depositary Receipt on ALAB Issued by INVX posted a gross margin of 75.13, reflecting its pricing power and cost economics. The operating margin of 22.75 and net profit margin of 30.74 provide insight into operational efficiency.
| Gross Margin | 75.13 |
| Operating Margin | 22.75 |
| Pretax Margin | 26.79 |
| Profit Margin | 30.74 |
| EBITDA Margin | 23.75 |